-
Viseon's minimally invasive spine visualization tool
Viseon's 4K MaxView system for minimally invasive spine surgery visualization has launched, and the first clinical cases were completed, the company said Aug. 15. -
Dr. Stephen Smith debuts Happe Spine's new spinal fusion system
Stephen Smith, MD, of Beacon Health System Memorial Hospital in South Bend, Ind., performed the first clinical case with Happe Spine's Integrate-C interbody fusion system. -
4 recent spine device approvals
Here are four spine device approvals since June 1: -
ZimVie's new Mobi-C disc earns FDA approval
ZimVie earned FDA approval for its new version of the Mobi-C cervical disc, the devicemaker said Aug. 10. -
Neuralink earns $280M funding round
Neuralink earned a $280 million series D funding round, the company said in an Aug. 7 tweet. -
Curiteva earns FDA nod for spinal instrument system
Curiteva received FDA 510(k) approval for its pedicle and sacroiliac joint navigation instruments, the medtech company said Aug. 8. -
Alphatec's Q2 revenue leaps 39%
Alphatec posted $117 million in second quarter sales. -
SynerFuse names CFO
SynerFuse named Bill Koschak as CFO, the company said Aug. 7. -
Smith + Nephew CFO to step down in 2024
Anne-Françoise Nesmes, CFO of medical technology company Smith + Nephew, will step down from the role during the second quarter of 2024. -
Stryker vs. Zimmer Biomet vs. Johnson & Johnson: How they compare in Q2 2023
Stryker, Johnson & Johnson and Zimmer Biomet posted their second quarter financial results for 2023, and data on their orthopedic sales. -
Globus Medical posts 10.6% increase in Q2 sales: 5 notes
Globus Medical on Aug. 3 posted second quarter sales of $291.6 million. -
How NuVasive is approaching headwinds ahead of merger
NuVasive's CEO Chris Barry remains confident the spine company will meet its planned merger with Globus Medical on schedule, he said in an Aug. 2 earnings call. -
ZimVie sees $23.4M net loss for Q2
ZimVie on Aug. 2 posted $224.9 million in second-quarter sales. -
NuVasive posts Q2 revenue growth ahead of Globus Medical merger
NuVasive on Aug. 2 posted $317.8 million in second quarter sales ahead of its merger with Globus Medical. -
DOCS Health completes enrollment in disc replacement study
DOCS Health of Los Angeles completed enrollment as primary investigators in Centinel Spine's 2-level SMART disc replacement clinical study, the practice said Aug. 1. -
Globus Medical launches Marvel growing rod system for scoliosis
Globus Medical launched its first product designed specifically for early onset scoliosis, the medtech company said July 31. -
Surgalign's businesses auctioned to Xtant Medical, Augmedics
Surgalign's digital health, hardware and biologics businesses have been sold to Xtant Medical and Augmedics through auctions. -
Icotec earns additional FDA nod for Vader system
Icotec's Vader pedicle system navigated instruments earned FDA 510(k) clearance, the medtech company said July 27. -
Michigan payer expands coverage of total disc replacement
Centinel Spine's Prodisc device earned positive coverage by a large commercial payer in Michigan starting Sept. 1. -
The state of AR in spine surgery in 2023
Augmented reality in spine surgery is growing. Last year, several AR spine systems hit the market, and this year surgeons are continuing to adopt the technology.
Page 3 of 50